v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (20,545,563) $ (14,873,182)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,038,066 4,149,240
Interest from amortization of loan issuance costs 90,124 213,829
Amortization of fair value of loan 90,321 71,215
Loss on extinguishment of debt 506,280 418,502
Change in fair value of warrant liability (0) 1,353,716
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) 15,636,336 1,560,445
(Gain) loss on disposal of property and equipment (455,092) 99,334
Stock-based compensation on stock options, RSUs & RSAs, net 2,861,795 1,043,464
Provision for credit losses (44,090) (3,014)
Change in operating lease assets and liabilities (188,686) (273,624)
Inventory write-offs to allowance 368,891 143,362
Deferred taxes (121,007) (221,977)
Changes in operating assets and liabilities, net of acquisitions:    
Trade accounts receivable (5,578,692) (2,626,267)
Other current assets (75,878) 91,027
Inventories (5,062,213) (1,385,690)
Prepaid expenses and deposits (2,242,800) (325,915)
Accounts payable and accrued liabilities 3,310,607 2,234,145
Net cash used in operating activities (10,225,188) (8,331,390)
Cash flows from investing activities:    
Purchase of property and equipment (6,268,334) (1,262,302)
Proceeds from sale of equipment 475,000 10,648
Net cash used in investing activities (12,793,445) (19,738,323)
Cash flows from financing activities:    
Proceeds from exercise of stock options 12,503 3,175
Proceeds from sale of common stock from Employee Stock Purchase Plan 24,862 14,385
Proceeds from issuance of common stock under public equity placement 112,337,122 0
Proceeds from issuance of common stock under private equity placement, net of fees 7,894,045 437,725
Proceeds from issuance of preferred stock under private equity placement, net of fees 0 18,675,026
Proceeds from issuance of warrants under private equity placement, net of fees 0 4,620,561
Borrowings on loans payable 0 6,659,596
Loan issuance costs 0 (597,465)
Payments on loans payable (5,471,522) (204,100)
Repayment of finance lease obligations (236,240) (187,626)
Net cash provided by financing activities 111,024,299 29,296,277
Effect of exchange rate on cash and cash equivalents 321,953 170,204
Change in cash and cash equivalents 88,327,619 1,396,768
Cash and cash equivalents, beginning of period 4,877,036 3,480,268
Cash and cash equivalents, end of period 93,204,655 4,877,036
Supplemental disclosure of cash flow information:    
Interest paid in cash 409,637 273,476
Income taxes paid 325,636 206,121
Supplemental disclosure of non-cash investing & financing activities:    
Purchase of equipment through finance lease arrangements 275,471 93,048
Operating right-of-use assets acquired in exchange for operating lease liabilities 1,956,911 0
Conversion of Debt into Common Stock, Preferred Stock, Warrants, and a Note [Member]    
Supplemental disclosure of non-cash investing & financing activities:    
Extinguishment of debt in exchange for common stock, preferred stock, warrants and a note 0 3,057,110
G5 Infrared [Member]    
Adjustments to reconcile net loss to net cash used in operating activities:    
Earnout payment for acquisition of G5, net of financing portion (3,813,587) 0
Cash flows from investing activities:    
Acquisition of G5 Infrared 0 (18,486,669)
Cash flows from financing activities:    
Earnout payment for acquisition of G5, net of operating portion (3,536,471) 0
Supplemental disclosure of non-cash investing & financing activities:    
Issuance of common stock for acquisition 3,572,314 4,872,068
Accrual of earnout consideration for acquisition 0 3,536,471
Amorphous Materials, LLC (“AML”) [Member]    
Adjustments to reconcile net loss to net cash used in operating activities:    
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) 700,000  
Cash flows from investing activities:    
Acquisition (7,000,111) 0
Supplemental disclosure of non-cash investing & financing activities:    
Issuance of common stock for acquisition 1,570,445 0
Accrual of earnout consideration for acquisition 1,780,000 0
Visimid Technologies [Member]    
Cash flows from financing activities:    
Earnout payment for acquisition of G5, net of operating portion 0 (125,000)
Supplemental disclosure of non-cash investing & financing activities:    
Issuance of common stock for acquisition $ 350,000 $ 713,946